查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
DNA 修復藥物市場與 COVID-19 影響分析，按藥物類型、按應用、按配銷通路、按國家和地區 - 2023-2030 年行業分析、市場規模、市場佔有率和預測
市場調查報告書
商品編碼
1339881

DNA 修復藥物市場與 COVID-19 影響分析，按藥物類型、按應用、按配銷通路、按國家和地區 - 2023-2030 年行業分析、市場規模、市場佔有率和預測

DNA Repair Drugs Market with COVID-19 Impact Analysis, By Drug Type, By Application, By Distribution Channel, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 300 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2022 年 DNA 修復藥物市場規模為 60.052 億美元，2023 年至 2030 年年複合成長率為 12.8%。

DNA 修復藥物市場-市場動態：

  • 不斷增加的癌症病例和不斷成長的醫療基礎設施刺激了市場需求。
  • 全球癌症病例不斷增加，極大提高了開發 DNA 損傷反應藥物以解決癌症未滿足需求的需求。這些藥物在提供特異性且有效耐受的治療方法以提高癌症生存率方面具有迄今為止聞所未聞的潛力。此外，DNA 修復藥物經常與個性化醫療的理念聯繫在一起，即根據患者的基因組成和特定突變提供個性化的醫療護理。因此，藥物可以針對選擇性基因譜進行設計；因此，這一趨勢有助於擴大這些藥物的潛在市場。然而，對於市場參與者來說，獲得 DNA 修復藥物的監管批准可能是一個耗時且複雜的過程，可能會限制全球市場的成長。此外，新興國家不斷增加的醫療保健支出和不斷發展的醫療保健基礎設施為 DNA 修復藥物製造商提供了巨大的成長機會。此外，這些地區對有效治療的需求未得到滿足，而且龐大的患者群體創造了有利的市場環境，預計這將促進 DNA 修復市場的成長。

DNA 修復藥物市場 - 主要見解：

  • 根據我們的研究分析師分享的分析，全球 DNA 修復藥物市場預計在預測期內（2023-2030 年）每年將以 12.8% 左右的年複合成長率成長
  • 由於人口中多種癌症的發病率和患病率不斷上升，DNA修復藥物行業預計將以顯著的速度成長，從而增加了需求
  • 根據藥物類型細分，預計 PARP 抑製劑將在不久的將來顯示出最大的市場佔有率
  • 從應用細分來看，心血管疾病是2022年的主導類型
  • 按地區分類，北美是預測期內的主要收入來源

DNA 修復藥物市場-細分分析：

  • 全球DNA修復藥物市場根據藥物類型、應用、配銷通路和地區進行細分。
  • 市場根據藥物類型分為三類：烷化劑、PARP抑製劑、拓撲異構酶抑製劑等。 PARP 抑製劑領域可能會佔據市場佔有率。使用 PARP 抑製劑來靶向同源重組修復 (HRR) 途徑、廣泛存在於轉移性前列腺癌和三陰性乳腺癌中的腫瘤，預計將擴大市場規模。此外，在患有 BRCA1/2 突變和 HRR 缺陷的癌症患者中使用 PARP 抑製劑（包括奧拉帕尼、尼拉帕尼和 rucaparib）預計將增強該細分市場的價值。
  • 該市場根據應用分為四類：神經退行性疾病、腫瘤、心血管疾病和中風。心血管疾病領域預計將在預測期內保持其主導地位。 DNA 修復藥物具有治療帕金森氏症和阿滋海默症等多種心血管疾病的潛力。此外，DNA修復可以提供治療選擇。
  • 根據配銷通路，市場分為兩類：零售藥房、醫院藥房和其他。醫院藥房業務成長迅速。該細分市場的成長歸因於癌症患病率的上升。此外，這些藥物的具體性質及其潛在的副作用，可能需要監測、仔細處理和管理，因此，這些因素可能會推動醫院藥房部門的成長。

DNA 修復藥物市場 - 地理洞察：

從地域上看，該市場廣泛分佈於北美、拉丁美洲、歐洲、亞太、中東和非洲地區。這些區域根據開展業務的國家進一步分類。

DNA修復藥物市場-競爭格局：

由於主要參與者的存在，DNA 修復藥物市場在全球範圍內高度集中。此外，不同的製造商在各自的地區佔有主要佔有率。由於癌症患病率的增加，發達市場和新興市場對技術先進產品的需求有所增加。市場參與者採取的成長戰略可能會推動全球市場。據此，這些戰略包括併購、創新產品發布、研發活動和合作夥伴關係。例如，2022 年 3 月，佛羅里達州立大學醫學院的研究人員做出了一項發現，改變了我們對人體 DNA 修復過程如何運作的理解，並可能導致癌症和其他疾病的新化療療法。

最近的發展：

此外，2023 年2 月，Artios Pharma Limited (Artios) 在正在進行的1/2 期試驗中引入了隨機、2 期擴展隊列，評估其共濟失調毛細血管擴張和Rad3 相關（“ATR”）抑製劑ART0380，用於治療與吉西他濱聯合治療鉑耐藥性卵巢癌。

該研究的主要特點：

  • 這項擬議的 DNA 修復藥物市場研究提供了市場規模（百萬美元）、年複合成長率（CAGR %）和預測估計（2023-2030 年），以 2022 年為基準年。
  • 該報告為客戶提供有關 DNA 修復藥物市場的最新趨勢見解。
  • 該研究報告闡明了不同細分市場/國家的潛在成長機會，並解釋了 DNA 修復藥物市場有吸引力的投資主張矩陣。
  • 總體報告確定了新的投資機會、老牌參與者面臨的挑戰以及 DNA 修復藥物市場維持的成長因素。
  • COVID-19 對 DNA 修復藥物市場規模、預測、年複合成長率和市場動態的影響將在研究範圍下詳細討論。還將詳細介紹新冠疫情后 DNA 修復藥物市場的情況。
  • 為了讓本報告的用戶全面了解 DNA 修復藥物市場，我們還對 DNA 修復藥物市場的競爭格局和關鍵創新者進行了分析。
  • 該研究包括成長前景映射分析，其中所有行業細分都根據其市場規模、成長率和吸引力進行基準測試。
  • 該報告提供了主要市場參與者的詳細公司概況，這些參與者將幫助用戶了解 DNA 修復藥物市場參與者的財務資訊和戰略舉措。
  • 此外，報告還揭示了全球和區域市場主要參與者的重要收購和兼併、合作和合資、新產品推出、研發、區域擴張。
  • 全球 DNA 修復藥物市場報告主要面向該行業的各個利益相關者，包括供應商、投資者、新進入者、分銷商和財務分析師。

目錄

第一章：DNA 修復藥物市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • DNA 修復藥物市場片段（按藥物類型）
    • DNA 修復藥物市場片段（按應用）
    • DNA 修復藥物市場片段（按配銷通路）
    • DNA 修復藥物市場片段（按國家/地區）
    • 按地區分類的 DNA 修復藥物市場片段
  • 競爭洞察

第 3 章：DNA 修復藥物主要市場趨勢

  • DNA修復藥物市場促進因素
    • 市場促進因素的影響分析
  • DNA修復藥物市場限制
    • 市場限制影響分析
  • DNA修復藥物市場機會
  • DNA修復藥物市場未來趨勢

第 4 章：DNA 修復藥物行業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：DNA 修復藥物市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的細分市場
    • 邊際成長部分
    • 最鬆散的部分
    • 邊際損失部分

第 6 章：DNA 修復藥物市場格局

  • 2022 年 DNA 修復藥物市場佔有率分析
  • 按主要製造商分類的故障數據
    • 既定玩家分析
    • 新興玩家分析

第 7 章：DNA 修復藥物市場 - 按藥物類型

  • 概述
    • 按藥物類型分類的細分市場佔有率分析
    • 烷基化劑
    • PARP抑製劑
    • 拓撲異構酶抑製劑
    • 其他

第 8 章：DNA 修復藥物市場 -按應用

  • 概述
    • 按應用的細分市場佔有率分析
    • 神經退行性疾病
    • 腫瘤學
    • 心血管疾病
    • 中風

第 9 章：DNA 修復藥物市場 - 按配銷通路

  • 概述
    • 按配銷通路分類的細分市場佔有率分析
    • 零售藥店
    • 醫院藥房
    • 其他

第 10 章：DNA 修復藥物市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美
    • 概述
    • DNA修復藥物北美主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按藥物類型）
    • 北美市場規模和預測（按應用）
    • 北美市場規模和預測（按配銷通路）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • DNA修復藥物歐洲主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模和預測（按藥物類型）
    • 歐洲市場規模和預測（按應用）
    • 歐洲市場規模和預測（按配銷通路）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • DNA修復藥物亞太地區主要製造商
    • 亞太地區市場規模和預測（按國家）
    • 亞太地區市場規模和預測（按藥物類型）
    • 亞太地區市場規模和預測（按應用）
    • 亞太地區市場規模和預測（按配銷通路）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳大利亞
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • DNA 修復藥物拉丁美洲主要製造商
    • 拉丁美洲市場規模和預測（按國家）
    • 拉丁美洲市場規模和預測（按藥物類型）
    • 拉丁美洲市場規模和預測（按應用）
    • 拉丁美洲市場規模和預測（按配銷通路）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • DNA修復藥物中東和非洲主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按藥物類型）
    • 中東和非洲市場規模及預測（按應用）
    • 中東和非洲市場規模及預測（按配銷通路）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 火雞
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 11 章：主要供應商分析 - DNA 修復藥物行業

  • 競爭儀表板
  • 公司簡介
    • Johnson & Johnson
    • Merck Kgaa
    • GlaxoSmithKline plc
    • Abbott Laboratories
    • F. Hoffmann-La Roche Ltd.
    • Abbvie Inc.
    • Pfizer Inc.
    • Amgen Inc.
    • Astrazeneca plc
    • Bristol-Myers Squibb Co.
    • Sanofi SA
    • Bayer AG
    • Eli Lilly
    • Gilead Sciences Inc.
    • Merck & Co. Inc.
    • Novartis AG

第 12 章：360 度分析師視角

第 13 章：附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯繫我們
Product Code: ANV1605

REPORT HIGHLIGHT

DNA repair drugs market size was valued at USD 6,005.2 Million in 2022, expanding at a CAGR of 12.8% from 2023 to 2030.

DNA repair drugs are defined as a class of pharmaceuticals that purpose to restore DNA functionality and integrity by helping to repair damaged DNA molecules. Moreover, these drugs are targeting particular DNA repair pathways and assist to restore DNA integrity as well as preventing the progression and development of several diseases, including cancer. The DNA repair drugs market is likely to witness significant growth due to increasing advancements and research activities in the field of molecular and genomics biology.

DNA Repair Drugs Market- Market Dynamics:

  • Increasing cases of cancer and growing healthcare infrastructure to fuel the market demand.
  • The increasing cases of cancer across the world have significantly raised the requirement for developing DNA damage response drugs for solving cancer unmet needs. These medications have hitherto unheard-of potential in providing a specific and effectively tolerated therapy method for boosting cancer survival rates. Moreover, DNA repair drugs are frequently associated with the idea of personalized medicine, where medical care is individualized based on a patient's genetic makeup as well as particular mutations. Thus, the drugs can be designed for selective genetic profiles; as a result, this trend helps to boost the potential market for these drugs. However, for market players, procuring regulatory approvals for DNA repair drugs could be a time-consuming and complex process that may restrain the market growth globally. Furthermore, the increasing healthcare expenditure and growing healthcare infrastructure in the emerging nation offer significant growth opportunities for DNA repair drug manufacturers. Additionally, these regions have an unmet need for effective treatments and a huge patient population creating a favorable market environment, which is projected to boost the DNA repair market growth.

DNA Repair Drugs Market- Key Insights:

  • As per the analysis shared by our research analyst, the global DNA repair drugs market is estimated to grow annually at a CAGR of around 12.8% over the forecast period (2023-2030)
  • The DNA repair drugs industry is projected to grow at a significant rate due to the rising incidence and prevalence of several cancers among the population increase the demand
  • Based on drug type segmentation, PARP inhibitors was predicted to show maximum market share in the near future
  • Based on application segmentation, cardiovascular diseases was the leading type in 2022
  • On the basis of region, North America was the leading revenue generator during the forecast period

DNA Repair Drugs Market- Segmentation Analysis:

  • The global DNA repair drugs market is segmented on the basis of drug type, application, distribution channel, and region.
  • The market is divided into three categories based on drug type: alkylating agents, PARP inhibitors, topoisomerase inhibitors, and others. The PARP inhibitors segment is likely to possess the market share. The use of PARP inhibitors to target homologous recombination repair (HRR) pathways, tumors extensively in metastatic prostate cancer, and triple-negative breast cancer is expected to augment the market size over. Additionally, the utilization of PARP inhibitors including olaparib, niraparib, and rucaparib, in cancer patients with BRCA1/2 mutation and deficiency in HRR is projected to strengthen the segment value.
  • The market is divided into four categories based on application: neurodegenerative diseases, oncological, cardiovascular diseases, and stroke. The cardiovascular diseases segment is expected to maintain its dominance over the forecast period. DNA repair drugs have the potential in treating numerous types of cardiovascular diseases like Parkinson's and Alzheimer's. Moreover, therapeutic options could be provided by DNA repair.
  • The market is divided into two categories based on distribution channels: retail pharmacies, hospital pharmacies, and others. The hospital pharmacies segment is accounted to witness speedy growth. The segment growth is attributed due to the rising prevalence of cancer. Moreover, the specific nature of these drugs and their potential side effects, are likely to require monitoring, careful handling, and administration, as a result, such factors may propel the hospital pharmacies segment growth.

DNA Repair Drugs Market- Geographical Insights:

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

DNA Repair Drugs Market- Competitive Landscape:

The DNA repair drugs market is highly concentrated across the globe owing to the presence of key players. Additionally, various manufacturers hold a major share in their respective regions. Demand for technologically advanced products has increased in developed as well as emerging markets, due to the increase in the prevalence of cancer. Growth strategies adopted by market players are likely to drive the global market. In line with this, the strategies include mergers & acquisitions, innovative product launches, R&D activities, and partnerships. For instance, in March 2022, a Florida State University College of Medicine researcher made a discovery that alters our understanding of how the body's DNA repair process works and may lead to new chemotherapy treatments for cancer and other diseases.

Recent Developments:

Furthermore, in February 2023, Artios Pharma Limited (Artios) introduced the initiation of a randomized, Phase 2 expansion cohort in the ongoing Phase 1/2 trial evaluating its ataxia telangiectasia and Rad3-related ("ATR") Inhibitor, ART0380, for the treatment of platinum-resistant ovarian cancer in combination with gemcitabine.

Key features of the study:

  • This proposed research study on DNA repair drugs market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year.
  • The report provides the client the latest up-to-date and trending insights about the DNA repair drugs market..
  • The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for DNA repair drugs market.
  • The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the DNA repair drugs market.
  • Impact of COVID-19 on DNA repair drugs market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on DNA repair drugs market post-COVID will also be covered.
  • In order to give the users of this report a comprehensive view on the DNA repair drugs market, we have also included competitive landscape and key innovator analysis for the DNA repair drugs market.
  • The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
  • The report offers detailed company profiling featuring major market participants who will help users to understand their financial information and strategic initiatives of players operating in the DNA repair drugs market.
  • In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
  • The global DNA repair drugs market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL DNA REPAIR DRUGS MARKET KEY PLAYERS

  • Johnson & Johnson
  • Merck Kgaa
  • GlaxoSmithKline plc
  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd.
  • Abbvie Inc.
  • Pfizer Inc.
  • Amgen Inc.
  • Astrazeneca plc
  • Bristol-Myers Squibb Co.
  • Sanofi S.A.
  • Bayer AG
  • Eli Lilly
  • Gilead Sciences Inc.
  • Merck & Co. Inc.
  • Novartis AG

GLOBAL DNA REPAIR DRUGS MARKET, BY DRUG TYPE

  • Alkylating Agents
  • PARP Inhibitors
  • Topoisomerase Inhibitors
  • Other

GLOBAL DNA REPAIR DRUGS MARKET, BY APPLICATION

  • Neurodegenerative Diseases
  • Oncological
  • Cardiovascular Diseases
  • Stroke

GLOBAL DNA REPAIR DRUGS MARKET, BY DISTRIBUTION CHANNEL

  • Retail Pharmacies
  • Hospital Pharmacies
  • Others

GLOBAL DNA REPAIR DRUGS MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. DNA Repair Drugs Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. DNA Repair Drugs Market Snippet by Drug Type
    • 2.1.2. DNA Repair Drugs Market Snippet by Application
    • 2.1.3. DNA Repair Drugs Market Snippet by Distribution Channel
    • 2.1.4. DNA Repair Drugs Market Snippet by Country
    • 2.1.5. DNA Repair Drugs Market Snippet by Region
  • 2.2. Competitive Insights

3. DNA Repair Drugs Key Market Trends

  • 3.1. DNA Repair Drugs Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. DNA Repair Drugs Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. DNA Repair Drugs Market Opportunities
  • 3.4. DNA Repair Drugs Market Future Trends

4. DNA Repair Drugs Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. DNA Repair Drugs Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. DNA Repair Drugs Market Landscape

  • 6.1. DNA Repair Drugs Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. DNA Repair Drugs Market - By Drug Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Drug Type, 2022&2030 (%)
    • 7.1.2. Alkylating Agents
    • 7.1.3. PARP Inhibitors
    • 7.1.4. Topoisomerase Inhibitors
    • 7.1.5. Other

8. DNA Repair Drugs Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2022&2030 (%)
    • 8.1.2. Neurodegenerative Diseases
    • 8.1.3. Oncological
    • 8.1.4. Cardiovascular Diseases
    • 8.1.5. Stroke

9. DNA Repair Drugs Market - By Distribution Channel

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Distribution Channel, 2022&2030 (%)
    • 9.1.2. Retail Pharmacies
    • 9.1.3. Hospital Pharmacies
    • 9.1.4. Others

10. DNA Repair Drugs Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022&2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. DNA Repair Drugs Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. DNA Repair Drugs Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. DNA Repair Drugs Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. DNA Repair Drugs Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. DNA Repair Drugs Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- DNA Repair Drugs Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Johnson & Johnson
    • 11.2.2. Merck Kgaa
    • 11.2.3. GlaxoSmithKline plc
    • 11.2.4. Abbott Laboratories
    • 11.2.5. F. Hoffmann-La Roche Ltd.
    • 11.2.6. Abbvie Inc.
    • 11.2.7. Pfizer Inc.
    • 11.2.8. Amgen Inc.
    • 11.2.9. Astrazeneca plc
    • 11.2.10. Bristol-Myers Squibb Co.
    • 11.2.11. Sanofi S.A.
    • 11.2.12. Bayer AG
    • 11.2.13. Eli Lilly
    • 11.2.14. Gilead Sciences Inc.
    • 11.2.15. Merck & Co. Inc.
    • 11.2.16. Novartis AG

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE DNA Repair Drugs Market: Drug Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Drug Type
  • TABLE Global DNA Repair Drugs Market, by Drug Type2018-2030 (USD Million)
  • TABLE DNA Repair Drugs Market: ApplicationSnapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global DNA Repair Drugs Market, by Application2018-2030 (USD Million)
  • TABLE DNA Repair Drugs Market: Distribution Channel Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Distribution Channel
  • TABLE Global DNA Repair Drugs Market, by Distribution Channel 2018-2030 (USD Million)
  • TABLE DNA Repair Drugs Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global DNA Repair Drugs Market, by Region 2018-2030 (USD Million)
  • TABLE North America DNA Repair Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE North America DNA Repair Drugs Market, by Drug Type, 2018-2030 (USD Million)
  • TABLE North America DNA Repair Drugs Market, by Application, 2018-2030 (USD Million)
  • TABLE North America DNA Repair Drugs Market, by Distribution Channel, 2018-2030 (USD Million)
  • TABLE Europe DNA Repair Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe DNA Repair Drugs Market, by Drug Type, 2018-2030 (USD Million)
  • TABLE EuropeDNA Repair Drugs Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe DNA Repair Drugs Market, by Distribution Channel, 2018-2030 (USD Million)
  • TABLE Asia Pacific DNA Repair Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific DNA Repair Drugs Market, by Drug Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific DNA Repair Drugs Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific DNA Repair Drugs Market, by Distribution Channel, 2018-2030 (USD Million)
  • TABLE Latin America DNA Repair Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America DNA Repair Drugs Market, by Drug Type, 2018-2030 (USD Million)
  • TABLE Latin America DNA Repair Drugs Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America DNA Repair Drugs Market, by Distribution Channel, 2018-2030 (USD Million)
  • TABLE Middle East and Africa DNA Repair Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa DNA Repair Drugs Market, by Drug Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa DNA Repair Drugs Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa DNA Repair Drugs Market, by Distribution Channel, 2018-2030 (USD Million)

List of Figures

  • FIGURE DNA Repair Drugs Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Drug Type segment market share analysis, 2022&2030
  • FIGURE Drug Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Application segment market share analysis, 2022&2030
  • FIGURE Application segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Distribution Channel segment market share analysis, 2022&2030
  • FIGURE Distribution Channel segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022&2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America DNA Repair Drugs Market share and leading players, 2022
  • FIGURE Europe DNA Repair Drugs Market share and leading players, 2022
  • FIGURE Asia Pacific DNA Repair Drugs Market share and leading players, 2022
  • FIGURE Latin America DNA Repair Drugs Market share and leading players, 2022
  • FIGURE Middle East and Africa DNA Repair Drugs Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe DNA Repair Drugs Market share analysis by country, 2022
  • FIGURE Germany DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific DNA Repair Drugs Market share analysis by country, 2022
  • FIGURE India DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America DNA Repair Drugs Market share analysis by country, 2022
  • FIGURE Brazil DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa DNA Repair Drugs Market share analysis by country, 2022
  • FIGURE Saudi Arabia DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA DNA Repair Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)